The association of therapeutic responses of rosuvastatin with the superoxide dismutase 2 enzyme gene polymorphism in coronary artery disease patients at najaf governorate
Keywords:
coronary artery disease, oxidative stress, SOD2 gene V16A polymorphism, PCR- RFLP, lipoproteins, cholesterolAbstract
Background: One of the most consistent hypotheses to explain atherogenesis postulates and reported to be involved in the pathogenesis of CAD is triggered by LDL oxidation caused by Superoxide anions. Rosuvastatin is a drug that lowers cholesterol, but it is now thought to improve cardiovascular morbidity and mortality through pleiotropic effects arising from their antioxidant, anti-inflammatory, and antiplatelet properties. In the mitochondria, manganese-dependent superoxide dismutase (MnSOD or SOD2) metabolizes the superoxide anions. A gene polymorphism in humans (Ala16Val-SOD2) causes the 16th amino acid of alanine (Ala) to become valine (Val).
Methods: We examined the lipid profile and SOD2 gene V16A polymorphism in 51 CAD patients who were on rosuvastatin 10 mg/day. During the investigation, the following factors were noted: Age, weight, BMI, blood pressure, TG (triglyceride), LDL (low density lipoprotein), HDL (high density lipoprotein), VLDL (very low density lipoprotein), and SOD2 (superoxide dismutase) are some of the variables that are taken into consideration. The AL- Sadar and AL-Hakeem Hospitals & Research Centre, the university of Kufa's pharmacy faculty, and other locations participated in this investigation. Several statistical analyses were used.
Result: SOD2 genes showed significant changes in allele and genotype distribution across CAD patients. After using rosuvastatin, serum ldl levels in CAD participants considerably fell.
Conclusion: The findings of this study show that Rosuvastatin decreased inflammation and oxidative stress in CAD and increased the capability of the antioxidant defense system, which was at least partially triggered by SNPs of SOD2. This improved the lipid profile in hyperlipidemia. These findings show the existence of an extra cardioprotective effect, which may be a pleiotropic effect or arise from a direct mechanism of action.
References
Agababyan IR, Sadykova Sh, Ruzieva AA. Assessment of the condition of patients after myocardial infarction complicated by chronic heart failure with cardioprotectors. Achievements of Science and Education. 2020;2(56):75-78.
Alyavi A, Uzokov J. Treatment of stable angina pectoris: focus on the role of calcium antagonists and ACE inhibitors. Ont Health Technol Assess Ser. 2017;15(9):1-12.
Alyavi B, Uzokov J. TCTAP C-156 Successful Percutaneous Coronary Intervention of a Left Circumflex Artery Departing from the Right Coronary Sinus. Journal of the American College of Cardiology. 2018;71(16 Supplement):S225-S226.
Valdivia A, Perez-Alvarez S, Aroca-Aguilar JD, Ikuta I, Jordan J. Superoxide dismutases: a physiopharmacological update. J Physiol Biochem. 2009;65:195-208.
Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012;586:585-595.
Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2008;17:3298-3305.
Mahalwar R, Khanna D. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. Eur J Pharmacol. 2013;711:57-62.
Duarte T, IBM da Cruz, Barbisan F, Capelleto D, Moresco RN, MMMF Duarte. The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism, 2015.
Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer. 2003;40:123-129.
Mitrunen K, Sillanpaa P, Katja V, Eskelinen M, Kosma VM, Behamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 2001;22:827-829.
Van Remmen H, Ikeno Y, Hamilton M, et al. Life -long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics. 2003;16:29-37.
Attatippaholkun W, Wikainapakul K. Predominant Genotypes and Alleles of Two Functional Polymorphisms in the Manganese Superoxide Dismutase Gene are Not Associated with Thai Cervical or Breast Cancer. Asian Pac. J. Cancer Prev. 2013;14:3955-3961.
Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, NakagawaHattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene: a predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. J. Biochem. Biophys. Res. Commun. 1996;226:561-565.
Kazemi E, Moradi M-T, Yari K, Mousavi SAR, Kahrizi D. Association between Manganese Superoxide Dismutase (MnSOD Val-9Ala) genotypes with the risk of generalized aggressive periodontitis disease. J. Cell. Mol. Biol. 2015;61(8):49-52.
Duarte T, Da Cruz IB, Barbisan F, Capelleto D, Moresco RN, Duarte MM. The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism. Pharmacogenomics J. 2016;(6):501-506. doi: 10.1038/tpj.2015.91. Epub 2016 Feb 16. PMID: 26882122.
Ali Işikli, Ayşe Kubat-Üzüm, İlhan Satman, Zeliha Matur, Emre Öge A, Cem İsmail Küçükali. Polymorphism is Associated with Abnormal Quantitative Sensory Testing in Type 2 Diabetic Patients. Noro Psikiyatr Ars. 2018;55(3):276-279. doi: 10.29399/npa.23027. PMID: 30224876; PMCID: PMC6138222.
Bresciani G, Cruz IBM, De Paz JA, Cuevas MJ, González-Gallego J. The MnSOD Ala16Val SNP: Relevance to human diseases and interaction with environmental factors, 2013.
Yongzhong Yang, Ziwei Zheng, Yuanyu Chen, Xuelin Wang, Hui Wang, Zhikang SI. A case control study on the relationship between occupational stress and genetic polymorphism and dyslipidemia in coal miners, 2023.
Grandhi GR, et al. Interplay of coronary artery calcium and risk factors for predicting CVD/CHD mortality: The CAC consortium [J]. JACC. Cardiovasc Imaging. 2020;13(5):1175-1186.
